What Researchers Did
Researchers randomised 45 patients with advanced esophageal cancer to receive either a 125I particle-integrated esophageal covered stent with hyperbaric oxygen or the stent alone.
What They Found
The treatment group showed a total effective rate of 80.7% (19.2% complete remission, 61.5% partial remission), significantly higher than the control group's 63.1% (10.5% complete remission, 52.6% partial remission) (p < 0.05). This combination therapy demonstrated good short- and long-term efficacy.
Canadian Relevance
This study was not conducted in Canada and does not have a direct Canadian connection.
Study Limitations
The study's relatively small sample size of 45 patients may limit the generalizability of its findings.